Yamaguchi, S., Motegi, H., Ishi, Y., Okamoto, M., & Terasaka, S. (2019). ACT-21 PRIMARY EXPERIENCE OF NOVOTTF THERAPY FOR THE PATIENTS WITH GBM IN OUR INSTITUTION. Neurooncol Adv.
Styl ChicagoYamaguchi, Shigeru, Hiroaki Motegi, Yukitomo Ishi, Michinari Okamoto, a Shunsuke Terasaka. "ACT-21 PRIMARY EXPERIENCE OF NOVOTTF THERAPY FOR THE PATIENTS WITH GBM IN OUR INSTITUTION." Neurooncol Adv 2019.
Citace podle MLAYamaguchi, Shigeru, et al. "ACT-21 PRIMARY EXPERIENCE OF NOVOTTF THERAPY FOR THE PATIENTS WITH GBM IN OUR INSTITUTION." Neurooncol Adv 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..